Diseases of protein conformation:: what do in vitro experiments tell us about in vivo diseases?

被引:61
作者
Buxbaum, JN [1 ]
机构
[1] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA
关键词
D O I
10.1016/j.tibs.2003.09.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Certain human diseases are associated with proteins that misfold and exhibit decreased solubility under physiological conditions. They result either from mutations that change the amino acid sequence of a protein, or from misfolded wild-type proteins, such as in Parkinson's disease and Alzheimer's disease. One subset - the amyloidoses - cause extracellular deposits that stain with the dye Congo red. Another subset is associated with intracellular deposits with non-Congophilic nuclear or cytoplasmic inclusions. Purified, recombinantly produced versions of some of the proteins that form intracellular aggregates can also display Congophilia, as well as other properties associated with the in vivo amyloidoses when examined under non-physiological conditions in vitro. Some of these purified proteins or protein fragments have never been identified as pathogenic in humans or animals. Despite potentially shared thermodynamic and kinetic processes involving the target molecules, the biology of these two subsets differs significantly.
引用
收藏
页码:585 / 592
页数:8
相关论文
共 63 条
[1]  
AILLES L, 1993, LAB INVEST, V69, P443
[2]   Chaperone suppression of α-synuclein toxicity in a Drosophila model for Parkinson's disease [J].
Auluck, PK ;
Chan, HYE ;
Trojanowski, JQ ;
Lee, VMY ;
Bonini, NM .
SCIENCE, 2002, 295 (5556) :865-868
[3]   Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases [J].
Bucciantini, M ;
Giannoni, E ;
Chiti, F ;
Baroni, F ;
Formigli, L ;
Zurdo, JS ;
Taddei, N ;
Ramponi, G ;
Dobson, CM ;
Stefani, M .
NATURE, 2002, 416 (6880) :507-511
[4]   Nonamyloidotic monoclonal immunoglobulin deposition disease - Light-chain, heavy-chain, and light- and heavy-chain deposition diseases [J].
Buxbaum, J ;
Gallo, G .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1999, 13 (06) :1235-+
[5]   The genetics of the amyloidoses [J].
Buxbaum, JN ;
Tagoe, CE .
ANNUAL REVIEW OF MEDICINE, 2000, 51 :543-569
[6]  
Calero M, 2000, MICROSC RES TECHNIQ, V50, P305, DOI 10.1002/1097-0029(20000815)50:4<305::AID-JEMT10>3.0.CO
[7]  
2-L
[8]   Designing conditions for in vitro formation of amyloid protofilaments and fibrils [J].
Chiti, F ;
Webster, P ;
Taddei, N ;
Clark, A ;
Stefani, M ;
Ramponi, G ;
Dobson, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (07) :3590-3594
[9]   AMYLOID FIBRIL IN HEREDITARY CEREBRAL-HEMORRHAGE WITH AMYLOIDOSIS (HCHWA) IS RELATED TO THE GASTROENTERO-PANCREATIC NEUROENDOCRINE PROTEIN, GAMMA TRACE [J].
COHEN, DH ;
FEINER, H ;
JENSSON, O ;
FRANGIONE, B .
JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 158 (02) :623-628
[10]   Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from α-synuclein in vitro [J].
Cohlberg, JA ;
Li, J ;
Uversky, VN ;
Fink, AL .
BIOCHEMISTRY, 2002, 41 (05) :1502-1511